These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 28893609)
1. Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy. Xu S; Zhu X; Huang W; Zhou Y; Yan D J Control Release; 2017 Nov; 266():36-46. PubMed ID: 28893609 [TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers. Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. He Y; Su Z; Xue L; Xu H; Zhang C J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977 [TBL] [Abstract][Full Text] [Related]
4. Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy. Jia YY; Zhang JJ; Zhang YX; Wang W; Li C; Zhou SY; Zhang BL Int J Pharm; 2020 Apr; 580():119190. PubMed ID: 32151664 [TBL] [Abstract][Full Text] [Related]
5. A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy. Han L; Wang T; Wu J; Yin X; Fang H; Zhang N Int J Nanomedicine; 2016; 11():6003-6022. PubMed ID: 27956831 [TBL] [Abstract][Full Text] [Related]
6. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs. Deshpande NU; Jayakannan M Biomacromolecules; 2017 Jan; 18(1):113-126. PubMed ID: 28064505 [TBL] [Abstract][Full Text] [Related]
8. Cisplatin-stitched α-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition. Wang H; Xiong Y; Wang R; Yu Y; Wang J; Hu Z; Sun C; Tu J; He D Eur J Pharm Sci; 2018 Jul; 119():189-199. PubMed ID: 29678612 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer. He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315 [TBL] [Abstract][Full Text] [Related]
10. Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity. Kumar P; Wasim L; Chopra M; Chhikara A AAPS PharmSciTech; 2018 Feb; 19(2):634-647. PubMed ID: 28948528 [TBL] [Abstract][Full Text] [Related]
11. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance. Song W; Tang Z; Shen N; Yu H; Jia Y; Zhang D; Jiang J; He C; Tian H; Chen X J Control Release; 2016 Jun; 231():94-102. PubMed ID: 26928530 [TBL] [Abstract][Full Text] [Related]
13. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. Mou Q; Ma Y; Zhu X; Yan D J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815 [TBL] [Abstract][Full Text] [Related]
14. Double-crosslinked nanocomposite hydrogels for temporal control of drug dosing in combination therapy. Wu C; Liu J; Zhai Z; Yang L; Tang X; Zhao L; Xu K; Zhong W Acta Biomater; 2020 Apr; 106():278-288. PubMed ID: 32084599 [TBL] [Abstract][Full Text] [Related]
15. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells. Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809 [TBL] [Abstract][Full Text] [Related]
16. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy. Chiang CS; Tseng YH; Liao BJ; Chen SY Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800 [TBL] [Abstract][Full Text] [Related]
17. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Tseng CL; Su WY; Yen KC; Yang KC; Lin FH Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990 [TBL] [Abstract][Full Text] [Related]
18. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756 [TBL] [Abstract][Full Text] [Related]
19. Reporter nanoparticle that monitors its anticancer efficacy in real time. Kulkarni A; Rao P; Natarajan S; Goldman A; Sabbisetti VS; Khater Y; Korimerla N; Chandrasekar V; Mashelkar RA; Sengupta S Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2104-13. PubMed ID: 27036008 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of cisplatin efficacy by lipid-CaO He C; Zhang X; Yan R; Zhao P; Chen Y; Li M; Chen C; Fan T; Lu Y; Wang C; Wu F; Lee RJ; Yang T; Xiang G Biomater Sci; 2019 Oct; 7(10):4260-4272. PubMed ID: 31402373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]